Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 426

1.

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

Amsterdam JD, Garcia-España F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C.

J Clin Psychopharmacol. 1998 Dec;18(6):435-40.

PMID:
9864074
[PubMed - indexed for MEDLINE]
2.

Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.

Amsterdam JD, Shults J.

Int Clin Psychopharmacol. 2005 Sep;20(5):257-64.

PMID:
16096516
[PubMed - indexed for MEDLINE]
3.

Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.

Amsterdam JD, Shults J, Brunswick DJ, Hundert M.

Bipolar Disord. 2004 Feb;6(1):75-81.

PMID:
14996144
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.

Amsterdam J.

J Clin Psychopharmacol. 1998 Oct;18(5):414-7.

PMID:
9790160
[PubMed - indexed for MEDLINE]
5.
6.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
[PubMed - indexed for MEDLINE]
7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
8.

Venlafaxine monotherapy in women with bipolar II and unipolar major depression.

Amsterdam JD, Garcia-España F.

J Affect Disord. 2000 Sep;59(3):225-9.

PMID:
10854639
[PubMed - indexed for MEDLINE]
9.

Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.

Romano S, Goodman W, Tamura R, Gonzales J.

J Clin Psychopharmacol. 2001 Feb;21(1):46-52.

PMID:
11199947
[PubMed - indexed for MEDLINE]
10.

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.

Amsterdam JD, Wang CH, Shwarz M, Shults J.

J Affect Disord. 2009 Jan;112(1-3):219-30. doi: 10.1016/j.jad.2008.03.029. Epub 2008 May 16.

PMID:
18486235
[PubMed - indexed for MEDLINE]
11.

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

Gilaberte I, Montejo AL, de la Gandara J, Perez-Sola V, Bernardo M, Massana J, Martin-Santos R, Santiso A, Noguera R, Casais L, Perez-Camo V, Arias M, Judge R; Fluoxetine Long-Term Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):417-24.

PMID:
11476126
[PubMed - indexed for MEDLINE]
12.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT.

J Clin Psychiatry. 2007 Aug;68(8):1246-56.

PMID:
17854250
[PubMed - indexed for MEDLINE]
13.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. Erratum in: Arch Gen Psychiatry. 2004 Feb;61(2):176.

PMID:
14609883
[PubMed - indexed for MEDLINE]
14.

Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.

Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.

J Neurol. 2003 Mar;250(3):347-51.

PMID:
12638027
[PubMed - indexed for MEDLINE]
15.

Fluoxetine treatment of depressed patients with comorbid anxiety disorders.

Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.

J Psychopharmacol. 2002 Sep;16(3):215-9.

PMID:
12236627
[PubMed - indexed for MEDLINE]
16.

Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose.

Beasley CM Jr, Nilsson ME, Koke SC, Gonzales JS.

J Clin Psychiatry. 2000 Oct;61(10):722-8.

PMID:
11078032
[PubMed - indexed for MEDLINE]
17.

Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.

Silverstone PH, Ravindran A.

J Clin Psychiatry. 1999 Jan;60(1):22-8.

PMID:
10074873
[PubMed - indexed for MEDLINE]
18.

Antidepressant monotherapy for bipolar type II major depression.

Amsterdam JD, Brunswick DJ.

Bipolar Disord. 2003 Dec;5(6):388-95. Review.

PMID:
14636362
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.

Amsterdam JD, Shults J.

Am J Psychiatry. 2010 Jul;167(7):792-800. doi: 10.1176/appi.ajp.2009.09020284. Epub 2010 Apr 1.

PMID:
20360317
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.

Schmidt ME, Fava M, Robinson JM, Judge R.

J Clin Psychiatry. 2000 Nov;61(11):851-7.

PMID:
11105738
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk